Universitätsklinikum Jena

Hospital


Location: Jena, Germany (DE) DE

ISNI: 0000000085176224

ROR: https://ror.org/035rzkx15

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Surgical treatment of endometrial cancer (2022) Emons G, Brucker SY, Fleisch MC, Mueller M, Juhasz-Boess E, Kiesel L, Runnebaum IB, et al. Journal article GAD-antibody associated temporal lobe epilepsy: T cells kill neurons, plasma cells and antibodies are bystanders (2022) Bien C, Troescher A, Mair K, De Juan LV, Becker A, Blümcke I, Finzel M, et al. Conference contribution Tailored Immunotherapy Approach With Nivolumab in Advanced Transitional Cell Carcinoma (2022) Grimm MO, Schmitz-Dräger BJ, Zimmermann U, Grün CB, Baretton GB, Schmitz M, Foller S, et al. Journal article (1 -> 3)-beta-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial (2022) Bloos F, Held J, Kluge S, Simon P, Kogelmann K, De Heer G, Kuhn SO, et al. Journal article Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9) (2022) Cesaro S, Ljungman P, Mikulska M, Hirsch HH, Von Lilienfeld-Toal M, Cordonnier C, Meylan S, et al. Journal article, Review article CHARACTERIZATION OF RELAPSES IN PATIENTS WITH GIANT CELL ARTERITIS (GCA) PATIENTS- DATA FROM THE REAL-LIFE TREATMENT AND SAFETY (REATS)-GCA COHORT (2022) Schönau V, Corte G, Ott S, Tascilar K, Hartmann F, Manger B, Hellmich B, et al. Conference contribution Clarity, clinical applicability and relevance of absolute contraindications in official 'Summaries of Product Characteristics' (SmPCs) (2022) Andrikyan W, Then M, Dürr P, Jung-Poppe L, Schuster A, Weisbach L, Farker K, et al. Conference contribution Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial (2022) Goerling U, Gauler T, Dietz A, Grünwald V, Knipping S, Guntinas-Lichius O, Frickhofen N, et al. Journal article Nested sampling for physical scientists (2022) Ashton G, Bernstein N, Buchner J, Chen X, Csányi G, Fowlie A, Feroz F, et al. Journal article, Review article Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations (2022) Eckardt JN, Stoelzel F, Kunadt D, Roellig C, Stasik S, Wagenfuehr L, Joehrens K, et al. Journal article